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MEETING ABSTRACT Open Access
New insights into HTLV entry
Claudine Pique1,2,3*, Olivier Hermine4, Francis W Ruscetti5, Kathryn S Jones6
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium. 5-8 June 2011
Insight into the long-lasting mystery of the HTLV-1
entry receptor was provided over the past several years
by the independent identification of three molecules
required for binding and entry into cells: heparan sulfate
proteoglycans (HSPG), the VEGF-165 receptor Neuropi-
lin 1 (NRP-1) and the ubiquitous glucose transporter
GLUT1. Further studies have indicated that these three
molecules work together to ensure virus binding and
ultimately, fusion of the viral and target cell membranes.
Interaction of the virus with this receptor complex is
mediated by the envelope glycoproteins (Env), which
consists of a complex formed between a surface (SU,
gp46) and a transmembrane (TM, gp21) subunit. Studies
prior to the characterization of the HTLV-1 receptor
complex identified domains and specific residues of the
HTLV-1 SU involved in the Env/receptor interactions
through either characterization of neutralizing antibo-
dies or peptides or analysis of Env mutants. We will
present our current model for HTLV-1 entry and revisit
the data about the functional domains of the SU in
regard to the recently acquired knowledge about the
three receptor molecules. We will also discuss the role
of these three molecules during the cell-cell and cell-
free infection of T cells and dendritic cells. Finally, we
will examine the similarities and differences between the
distinct members of the HTLV family in their receptor
usage.
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